11th European Congress: Perspectives in Lung Cancer
Amsterdam RAI Convention Centre
Europaplein 22
Amsterdam, The Netherlands
11th European Congress: Perspectives in Lung Cancer

Schedule of Presentations:

Friday, March 5, 2010
08:15:00 Welcome and introduction Pieter E. Postmus
08:20:00 Session I: The changing epidemiology of lung cancer
08:30:00 Molecular epidemiology of lung cancer Paolo Boffetta
08:50:00 Changing demographics of smoking and its effects during therapy Egbert   F. Smit
09:10:00 Women and lung cancer Silvia Novello
09:30:00 Smoking cessation techniques: An update Jacques Cornuz
09:50:00 Clinical case of never smoker patient Egbert   F. Smit
10:10:00 Coffee break
10:15:00 Session II: Diagnosis and staging
10:40:00 Evaluation of the pulmonary solitary nodule Maurizio Zompatori
11:20:00 Early detection of lung cancer Robert J. Van Klaveren
11:40:00 Diagnostic challenges for thoracic pathologist Keith Kerr
12:00:00 The implementation of the new IASLC-UICC TNM staging system Peter Goldstraw
12:20:00 Lunch break
12:25:00 Session III: Diagnosis and treatment of the early NSCLC
14:20:00 Physiological assessment of patients with resectable NSCLC Kristiaan Nackaerts
14:40:00 Mediastinal staging: Surgical pro Paul E. Y. Van Schil
15:00:00 Mediastinal staging: Surgical contra Stefano Gasparini
15:20:00 Adjuvant systemic therapy Christian Manegold
15:40:00 Is the neo-adjuvant approach better than adjuvant approach? Virginie Westeel
16:00:00 Coffee break
16:15:00 Session IV: New agents in lung cancer
16:30:00 Agents against type 1 insulin-like growth factor receptor (IGF-R1) Luis Paz Ares
16:50:00 Apoptotic agents Dean Fennell
17:10:00 HDAC and PARP inhibitors Suresh Ramalingam
17:30:00 Vaccines: Any expectations? Johan F. Vansteenkiste
17:50:00 Adjourn
Saturday, March 6, 2010
08:00:00 Welcome and introduction Giorgio Vittorio Scagliotti
08:05:00 Session V: Radiotherapy in lung cancer
08:05:00 Stereotactic radiotherapy in early NSCLC
08:30:00 Radiotherapy in locally advanced NSCLC
08:50:00 Palliative radiotherapy Umberto Ricardi
09:10:00 Prophylactic brain irradiation in lung cancer Cécile Le Pechoux
09:30:00 Clinical case
09:50:00 Coffee break
09:55:00 Session VI: Changing the treatment paradigms in front line metastatic NSCLC
10:20:00 Histology in the therapeutic decision-making process Giorgio Vittorio Scagliotti
10:40:00 Anti-angiogenic agents: Where we are? Martin Reck
11:00:00 Debate: Maintenance chemotherapy – cytotoxic agents versus targeted agents Federico Cappuzzo
11:40:00 Interventional bronchology in the management of NSCLC Thomas G. Sutedja
12:00:00 Lunch symposium supported by Roche
12:05:00 Session VII: Where do we stand with biomarkers?
13:30:00 How to design a clinical study using biomarkers
13:50:00 Using biomarkers to predict the effects of anti-angiogenetic agents
14:10:00 Molecular predictors of response and resistance to EGFR-inhibiting agents Lucini Crino
14:30:00 Pharmacogenomic approaches Luis Paz Ares
14:50:00 Third line and beyond
14:55:00 Session VIII: Mesothelioma
15:10:00 Diagnosis and staging Paul Baas
15:30:00 Treatment of mesothelioma Jan P. Van Meerbeeck
15:50:00 Clinical case
16:00:00 Adjourn
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.